A fundamental operate of cells is that they act in response to their environments. It is sensible, then, {that a} aim of scientists is to manage that course of, making cells reply how they need to what they need.
One avenue for this ambition is cell receptors, which operate like ignition slots on a cell, requiring keys – reminiscent of particular hormones, medication, or antigens – to start out up particular mobile actions. There are already artificial receptors that give us some management over this sequence of occasions, most famously the chimeric antigen receptors utilized in CAR-T cell most cancers remedy. However current artificial receptors are restricted within the number of keys they’ll settle for and the actions they’ll set off.
Now, detailed in a paper printed Dec. 4 in Nature, Stanford researchers have developed a brand new artificial receptor that accommodates a broader vary of inputs and produces a extra various set of outputs.
This innovation, referred to as “Programmable Antigen-gated G protein-coupled Engineered Receptors” (PAGER), is constructed round G protein-coupled receptors, a set of over 800 proteins within the human physique that activate molecular switches contained in the cell, referred to as G-proteins, to manage many very important capabilities. The researchers demonstrated PAGER’s versatility by efficiently controlling neuronal exercise, triggering immune responses, and delivering therapeutic remedies in lab experiments.
I believe PAGER has potential for affect, each within the G protein coupled receptor biology area, and in artificial circuits or cell-based therapies. If you put a know-how on the market, it is all the time thrilling to see all of the artistic ways in which folks use and rework the know-how in ways in which you by no means even imagined. There’s a lot extra that is doable.”
Alice Ting, professor of genetics on the Faculty of Medication and of biology within the Faculty of Humanities and Sciences and senior creator of the paper
Holding the keys
Whereas G-protein coupled receptors can activate numerous mobile actions, researchers had beforehand averted them for programmable functions as a result of customizing their “keys” was difficult, actually requiring researchers to direct the evolution of the receptors for years to create only one desired possibility.
“G-protein coupled receptors, usually, may be activated by particular small molecules that bind in a pocket within the receptor,” defined Nicholas Kalogriopoulos, a postdoctoral fellow within the Ting lab and co-lead creator of the paper. “Primarily, what we did is fuse one thing that blocks that pocket, and it solely opens up when it binds one thing you have chosen.”
In different phrases, the researchers added a layer of safety – a nanobody coupled with a peptide antagonist – that guards the ignition. Like a automotive’s proprietor contemplating whether or not to lend it to a good friend, the nanobody and peptide antagonist solely enable for insertion of the important thing underneath particular circumstances. This configuration not solely limits entry to the receptor but in addition makes it doable to swap out the “proprietor” to vary the entry standards. This modularity, mixed with the plentiful affect of G-proteins, means PAGER may allow an unimaginable variety of cell responses.
All of it works
To place PAGER by way of its paces, the researchers partnered with Ivan Soltesz, the James R. Doty Professor in Neurosurgery and Neurosciences at Stanford Medication, and Yulong Li, the Boya Professor at Peking College, who’re each co-authors of the paper.
“The very collaborative surroundings of Stanford expedited the examine. I believe it actually led to the success of the experiment and the mission,” mentioned Reika Tei, a postdoctoral fellow within the Ting lab and co-lead creator of the paper.
In lab experiments, the researchers used PAGER to change neuronal exercise in a cell tradition and a bit of mouse mind, management T-cell migration, change the inflammatory state of macrophages (a kind of immune cell), and secrete therapeutic antibodies in response to the presence of tumor antigens.
“We did not count on all 4 functions to work instantly, however they did, which made me really feel actually good in regards to the know-how,” mentioned Ting. “We did not have any software the place we tried it and it did not work – which isn’t a promise to everybody that it will work for them – nevertheless it was strong.”
The following steps for PAGER contain exploring completely different functions, simplifying its construction, and enhancing its capacity to function autonomously – reminiscent of robotically delivering medication upon receptor binding. Though nonetheless in early levels, the researchers are assured in PAGER’s potential, particularly as different labs start to experiment with it.
“We have made PAGER simply programmable, and we’d love to use it to all kinds of locations, however we do not have the experience for that,” mentioned Kalogriopoulos. “We want individuals who truly examine the biology of a particular illness or mobile operate as a result of they know the right inputs and outputs. So I am actually excited for folks to take it and begin utilizing it.”
Supply:
Journal reference:
Kalogriopoulos, N. A., et al. (2024). Artificial GPCRs for programmable sensing and management of cell behaviour. Nature. doi.org/10.1038/s41586-024-08282-3.